Wuxi Pharmatech Investment Holdings (cayman) Inc. - Net Worth and Insider Trading

Wuxi Pharmatech Investment Holdings (cayman) Inc. Net Worth

The estimated net worth of Wuxi Pharmatech Investment Holdings (cayman) Inc. is at least $242 Million dollars as of 2025-06-11. Wuxi Pharmatech Investment Holdings (cayman) Inc. is the 2201 Interest of corporation controlled by you of Hua Medicine and owns about 73,829,635 shares of Hua Medicine (HKSE:02552) stock worth over $242 Million. Details can be seen in Wuxi Pharmatech Investment Holdings (cayman) Inc.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Wuxi Pharmatech Investment Holdings (cayman) Inc. has not made any transactions after 2021-08-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Wuxi Pharmatech Investment Holdings (cayman) Inc.

Wuxi Pharmatech Investment Holdings (cayman) Inc. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Wuxi Pharmatech Investment Holdings (cayman) Inc. owns 1 companies in total, including Hua Medicine (HKSE:02552) .

Click here to see the complete history of Wuxi Pharmatech Investment Holdings (cayman) Inc.’s form 4 insider trades.

Insider Ownership Summary of Wuxi Pharmatech Investment Holdings (cayman) Inc.

Ticker	Company	Transaction Date	Type of Owner
HKSE:02552	Hua Medicine	2021-08-26	2201 Interest of corporation controlled by you

Wuxi Pharmatech Investment Holdings (cayman) Inc. Latest Holdings Summary

Wuxi Pharmatech Investment Holdings (cayman) Inc. currently owns a total of 1 stock. Wuxi Pharmatech Investment Holdings (cayman) Inc. owns 73,829,635 shares of Hua Medicine (HKSE:02552) as of August 26, 2021, with a value of $242 Million.

Latest Holdings of Wuxi Pharmatech Investment Holdings (cayman) Inc.

Ticker	Company	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
HKSE:02552	Hua Medicine	2021-08-26	73,829,635	3.28	242,161,203

Holding Weightings of Wuxi Pharmatech Investment Holdings (cayman) Inc.

Wuxi Pharmatech Investment Holdings (cayman) Inc. Form 4 Trading Tracker

According to the SEC Form 4 filings, Wuxi Pharmatech Investment Holdings (cayman) Inc. has made a total of 1 transactions in Hua Medicine (HKSE:02552) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Hua Medicine is the sale of 200,000 shares on August 26, 2021, which brought Wuxi Pharmatech Investment Holdings (cayman) Inc. around $918,760.

Insider Trading History of Wuxi Pharmatech Investment Holdings (cayman) Inc.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Wuxi Pharmatech Investment Holdings (cayman) Inc. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Wuxi Pharmatech Investment Holdings (cayman) Inc. Ownership Network

Ownership Network List of Wuxi Pharmatech Investment Holdings (cayman) Inc.

No Data

Ownership Network Relation of Wuxi Pharmatech Investment Holdings (cayman) Inc.

Wuxi Pharmatech Investment Holdings (cayman) Inc. Owned Company Details

What does Hua Medicine do?

Who are the key executives at Hua Medicine?

Wuxi Pharmatech Investment Holdings (cayman) Inc. is the 2201 Interest of corporation controlled by you of Hua Medicine. Other key executives at Hua Medicine include 2202 Interest of your spouse Hong Jane Xingfang , 2101 Beneficial owner Chen Li , and 2306 Nominee for another person Hlyy Limited .

Hua Medicine (HKSE:02552) Insider Trades Summary

Over the past 18 months, Wuxi Pharmatech Investment Holdings (cayman) Inc. made no insider transaction in Hua Medicine (HKSE:02552). Other recent insider transactions involving Hua Medicine (HKSE:02552) include a net sale of 0 shares made by Chen Li , and a net sale of 0 shares made by Hong Jane Xingfang .

In summary, during the past 3 months, insiders sold 0 shares of Hua Medicine (HKSE:02552) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Hua Medicine (HKSE:02552) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Hua Medicine (HKSE:02552)'s detailed insider trading history can be found in Insider Trading Tracker table.

Hua Medicine Insider Transactions

No Available Data

Wuxi Pharmatech Investment Holdings (cayman) Inc. Mailing Address

Above is the net worth, insider trading, and ownership report for Wuxi Pharmatech Investment Holdings (cayman) Inc.. Currently GuruFocus does not have mailing address information for Wuxi Pharmatech Investment Holdings (cayman) Inc..

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.